جستجوی استاد راهنمای دانشگاهی

Michael Yeager, PhD, serves as an Associate Clinical Professor in the School of Medicine at the University of Colorado Denver, focusing on cardiopulmonary pathophysiology with emphasis on pulmonary hypertension and heart failure mechanisms. He completed his PhD at the University of Colorado Health Sciences Center in 2002, establishing foundational expertise in vascular biology. His research program investigates immunological and molecular drivers of pulmonary vascular disease, particularly the roles of autoantibodies, fibrocytes, and inflammatory cascades in disease progression. Analysis of his 14 publications (2012-2015) reveals consistent exploration of biomarker discovery, vascular remodeling, and immune dysregulation across pediatric and adult pulmonary hypertension. Key methodological approaches include proteomics, animal modeling, and molecular interrogation of cellular stress responses, with significant translational implications for personalized therapeutic strategies. Professional recognitions include: Outstanding Faculty award from Tau Beta Pi (2019) Chancellor's Teaching Recognition Award from the University of Colorado (2016) Dr. Yeager maintains active clinical research collaborations at Children's Hospital Colorado while mentoring within the medical school curriculum. His work bridges basic science discovery with clinical application through ongoing investigations into endothelial dysfunction and inflammatory mediators. Affiliated with the Department of Medicine, he contributes to pulmonary vascular research initiatives and participates in professional societies including the American Thoracic Society, American Heart Association, and T21 Research Society.

• Pulmonary vasculature
• Heart Failure
• Cardiopulmonary Immunology

Margaret Bublitz is Associate Professor at Brown University with joint appointments in the Department of Psychiatry and Human Behavior , Department of Medicine , and Department of Obstetrics and Gynecology . She holds secondary appointments at the School of Public Health as Senior Investigator and Behavioral and Social Sciences faculty member. Dr. Bublitz earned her PhD in Clinical Psychology (2010) from the University of British Columbia, followed by postdoctoral training in Cardiovascular Behavioral Medicine at Brown Medical School. Her research focuses on: Psychological stress pathways to adverse perinatal outcomes Maternal childhood maltreatment effects on neurobiology Mindfulness interventions for hypertension and preterm birth prevention Her 15 most recent publications demonstrate expertise in perinatal mental health , sleep-disordered breathing , HPA axis regulation , and fetal neurodevelopment , with significant collaborations in neuroendocrinology and maternal-infant health disparities . Scientific recognition includes: 2024-2025 Global Fulbright Scholarship 2022 Brown Early Career Research Achievement Award Multiple NIH and foundation grants exceeding $6 million Bublitz leads NIH-funded projects examining mechanisms of mindfulness training (R01HL157288) and serves as mentor in the MORPHE Trial for digital maternal health innovations. She is a licensed psychologist and active member of Brown's Stress, Trauma and Resilience (STAR) Institute and Mindfulness Center .

• Perinatal Mental Health
• Integrated Behavioral Health
• Mindfulness-Based Interventions
• +۶ مورد دیگر

Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.

• Pulmonary Arterial Hypertension
• Critical Care Medicine
• Pediatric Cardiology
• +۴ مورد دیگر

Clifford W. Bogue, MD , is the Waldemar Von Zedtwitz Professor of Pediatrics, Chair of the Department of Pediatrics at Yale School of Medicine, and Chief of Pediatrics for the Yale New Haven Health System. He has been a faculty member at Yale since 1993 and has held numerous leadership roles, including Interim Chairman of Pediatrics, Chief Medical Officer of Yale-New Haven Children’s Hospital, and Director of Pediatric Critical Care programs. Education: BA and MD from the University of Virginia; Residency and Chief Residency at Vanderbilt University; Fellowship in Pediatric Critical Care at Yale. Dr. Bogue is a pediatric critical care specialist whose research centers on the molecular mechanisms of organ development, particularly the role of the Hhex gene in liver, cardiovascular, and lung organogenesis. His lab used mouse models to uncover critical genetic pathways in embryonic development, with implications for regenerative medicine. His recent work also extends into pediatric public health, critical care infrastructure, and health equity. An analysis of his recent publications reveals a sustained focus on developmental genetics, with increasing engagement in clinical and policy-oriented research in pediatrics. His work spans molecular biology, translational models, and national health initiatives, reflecting a broad scholarly impact. His scientific honors include: President of the American Pediatric Society (2024–2025) Norman J. Siegel Faculty Award Marna P. Borgstrom Lifetime Achievement Award Consistent recognition in Best Doctors in America since 2004 Honorary M.A. from Yale University Dr. Bogue has been deeply involved in training the next generation of physician-scientists, serving as PI of an NIH T32 program, Training Director of the Yale Child Health Research Center (K12), and mentor in the MD/PhD program. He has contributed to national pediatric research policy through roles in the American Academy of Pediatrics, NIH advisory committees, and the Charles H. Hood Foundation. He leads or has led significant research initiatives, including an NIH-funded program on cardiopulmonary development and the Bedside to Bench seminar for medical students. His leadership extends to national boards and editorial roles, including Section Editor for Current Opinion in Pediatrics .

• Pediatric Critical Care Medicine
• Developmental Biology
• Organogenesis
• +۷ مورد دیگر

Xiaochen He serves as an Instructor in the Department of Physiology & Biophysics at the University of Mississippi Medical Center's School of Medicine, where he focuses on cardiovascular research and teaching within this foundational medical science department. His research program centers on the intersection of cardiac pathophysiology and immunometabolism, with core interests including: Mechanisms of immune-mediated cardiac inflammation in heart failure Role of T cell subsets (Th17, γδ T, CD8+) in pressure overload models Molecular regulation by IL-12 family cytokines and metabolic enzymes (TIGAR, SIRT3) Endothelial dysfunction in cardiac hypertrophy and failure progression Therapeutic interventions targeting inflammatory pathways Analysis of Dr. He's recent publications (2022-2025) reveals a concentrated research trajectory investigating how specific immune pathways drive heart failure progression. His work consistently employs genetic mouse models to demonstrate that IL-12β inhibition, TIGAR deficiency, and selenium supplementation attenuate cardiac inflammation and dysfunction, while CD8+ T cell metabolic reprogramming exacerbates disease. Key discoveries include GPR174's role in Th17 differentiation and NK1.1 signaling's contribution to cardiopulmonary inflammation, establishing critical immune-metabolic axes in heart failure pathogenesis. No scientific awards were documented in the available profile information. Current departmental records indicate no graduate students are formally listed under Dr. He's mentorship, and no research grants are specified in the public profile. Details regarding laboratory infrastructure, research teams, or collaborative networks were not provided in the available institutional documentation.

• Heart Failure
• Cardiovascular Immunology
• Cardiac Inflammation
• +۳ مورد دیگر

Mostafijur Rahman is an Assistant Professor of Environmental Health Sciences at Tulane University's School of Public Health and Tropical Medicine. His research leverages large environmental health datasets to study climate impacts on neurodevelopment, mental health, and cardiopulmonary outcomes. Research focuses on: Air pollution impacts on autism spectrum disorders Health effects of extreme heat and air pollution co-exposures Environmental justice and health disparities Climate vulnerability in urban populations Recent publications analyze prenatal exposures to particulate matter, mortality risks from extreme temperatures, and adaptation strategies in vulnerable communities. Methodological strengths include advanced statistical modeling of chemical mixtures and mixed-methods approaches. Awards and honors: Emerging Investigator designation by AJRCCM (2022) Best Poster Award, NYC Epidemiology Forum (2019) Dr. Morton Lippmann Scholarship, AIHA (2018)

• Environmental Epidemiology
• Air Pollution
• Climate Change and Health
• +۲ مورد دیگر

Mansoureh Eghbali, PhD, is a Professor in the Department of Anesthesiology at the David Geffen School of Medicine, University of California, Los Angeles. Her research program investigates molecular mechanisms of cardiovascular and pulmonary diseases with emphasis on sex-specific pathophysiology. She leads an active NIH-funded laboratory focused on pulmonary hypertension, myocardial ischemia-reperfusion injury, and the role of RNA-binding proteins in vascular remodeling. Her research integrates multiomics approaches to explore: Sex chromosome influences (Y-gene Uty) in pulmonary vascular protection MicroRNA regulation of cardiac fibrosis and calcification (e.g., miR-129-5p/Asporin axis) Gut-heart-lung interactions in diet-induced pulmonary hypertension Endothelial subpopulations (TM4SF1+) in disease progression Analysis of her recent publications reveals strong emphasis on: Integrative multiomics in vascular diseases Sex differences in drug responses Novel therapeutic targeting of RNA-binding proteins Cross-organ communication in cardiopulmonary pathologies She directs multiple NIH grants including: R01HL159865: Role of Chromosome Y gene, Uty (2021-2025) R01HL147586: Role of miR125 in pulmonary hypertension (2019-2023) R01HL129051: Role of miR193 in oxidized lipid-induced PH (2016-2021) R01HL131182: Epigenetic regulation by X chromosome (2016-2021)

• Pulmonary Hypertension
• Myocardial Ischemia-Reperfusion Injury
• Sex Differences in Cardiovascular Disease
• +۳ مورد دیگر

Taylor Adams is a Researcher at the Yale School of Medicine's Internal Medicine Department, affiliated with the Kaminski Lab. Their work focuses on pulmonary fibrosis mechanisms, lung aging, and single-cell profiling, with a particular emphasis on epigenetic and immunological pathways. Adams collaborates closely with senior investigators like Naftali Kaminski, contributing to studies on fibrogenesis, drug development, and cellular dynamics in lung diseases. Research interests include understanding how epigenetic changes, microRNA regulation, and immune-cell interactions drive fibrotic processes. Recent work explores novel biomarkers for disease progression and non-invasive diagnostic methods. Adams' publications highlight advancements in spatial transcriptomics, somatic mutation analysis in aging lungs, and the role of GPR87 and CD103+ dendritic cells in fibrosis. Key contributions include identifying aberrant basaloid cells in IPF and developing computational tools like SDePER for deconvolving spatial transcriptomic data. Their lab's interdisciplinary approach integrates genomics, bioinformatics, and experimental models to translate findings into therapeutic strategies.

• Pulmonary Fibrosis
• Lung Aging
• Single-Cell Profiling
• +۳ مورد دیگر

Kevin S. Lee, Ph.D., is a Professor in the Department of Neuroscience at the University of Virginia School of Medicine. His research is centered on understanding the mechanisms of neuronal injury and developing therapeutic interventions for neurological disorders such as stroke, epilepsy, and glioblastoma. He leads a multidisciplinary laboratory focused on neuroinflammatory pathways and non-invasive brain circuit modulation. Research Interests: Mechanisms of neuronal injury in stroke and epilepsy Neuroinflammation in cognitive dysfunction post-cardiopulmonary bypass Therapeutic development using trans-sodium crocetinate Non-invasive disconnection of brain circuitry using focused ultrasound Pathophysiology of cortical malformations and seizures Neuroinflammatory contributions to glioblastoma multiforme Publication Trends: His recent publications demonstrate a strong focus on translational neuroscience, particularly combining molecular interventions with advanced neuromodulation techniques. A recurring theme is the use of non-invasive, targeted neuronal injury to study and treat seizure disorders and cognitive decline, often employing rodent models and collaborations with imaging experts. The work spans neuroengineering, neuroimmunology, and neuropharmacology, reflecting a highly interdisciplinary approach. Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: While specific students and grant funding are not listed, Dr. Lee appears to lead an active research lab with multiple ongoing projects and collaborations. His publication record suggests sustained funding and mentorship of junior researchers. He frequently collaborates with experts in neurosurgery, radiology, and immunology, indicating a team-based research environment. Laboratory and Research Team: The Lee Lab conducts multidisciplinary investigations into neuronal injury and repair. Research projects include stroke treatment, glioblastoma, and neuroinflammatory mechanisms. The lab collaborates extensively, particularly with Dr. Max Wintermark and others in neuroscience and radiology, suggesting integration within a larger research consortium at UVA.

• Neuroscience
• Neuronal Injury
• Neuroinflammation
• +۷ مورد دیگر

Stefano Guerra, MD, PhD, MPH is a Professor of Medicine at the University of Arizona and holds the prestigious Henry E. Dahlberg Chair in Asthma Research. He serves as Director of Population Sciences at the Asthma and Airway Disease Research Center (A2DRC) and is a Professor at the UA Mel & Enid Zuckerman College of Public Health and the UA BIO5 Institute. His work bridges clinical medicine, public health, and basic science research in respiratory diseases. Dr. Guerra's research focuses on the developmental origins of respiratory diseases, particularly asthma. His work spans several key areas including: Early life determinants of asthma and lung function development from fetal life through adulthood The role of epigenetics and biomarkers like CC16 (Club Cell Secretory Protein) in respiratory health Longitudinal cohort studies tracking respiratory health from birth to adulthood Environmental influences on respiratory health, including air pollution effects Population-level patterns of asthma and related conditions across diverse populations His most recent publications reveal emerging trends in understanding the connections between early life exposures, metabolic factors, and long-term respiratory outcomes. Notably, his work has identified links between childhood insulin-related asthma and reduced lung function, creatine kinase levels in childhood asthma, and the role of early growth patterns in adult spirometric restriction. His research increasingly integrates multi-omics approaches with traditional epidemiological methods. Dr. Guerra has been honored with The Henry E. Dahlberg Chair in Asthma Research , a distinguished position recognizing his significant contributions to asthma research. Dr. Guerra serves as Principal Investigator for several major longitudinal studies including the Tucson Children's Respiratory Study (TCRS) and the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD). He is currently leading the CC16 COVID Pilot study. His work has been supported by numerous grants that enable these long-term investigations into respiratory health across the lifespan. As Director of Population Sciences at the Asthma and Airway Disease Research Center (A2DRC), Dr. Guerra leads a multidisciplinary team focused on understanding the population-level determinants of asthma and airway diseases. His work bridges clinical care, public health, and basic science research to address respiratory health challenges from multiple angles.

• Asthma Research
• Respiratory Epidemiology
• Lung Function Development
• +۴ مورد دیگر

Dr. Christopher Kline is an Associate Professor in the Department of Health and Human Development at the University of Pittsburgh's School of Education. His research focuses on the interplay between physical activity, sleep, and cardiometabolic health, with a particular emphasis on sleep disturbances like insomnia and sleep apnea. He holds a BA in Sports Science from Malone College and an MS/PhD in Exercise Science from the University of South Carolina. Prior to joining the School of Education in 2015, he served as an Assistant Professor in the Department of Psychiatry at the University of Pittsburgh. Dr. Kline’s research group, ExerSleep, explores how physical activity can mitigate sleep disorders and their health impacts, while also studying how poor sleep affects physical activity patterns. His work spans topics such as athletic performance optimization through sleep science, circadian rhythms, and the combined effects of sleep and exercise on cardiovascular health. He has contributed to large-scale studies like the Pregnancy 24/7 cohort and the Sleep and Dementia Consortium. Key research interests include sleep architecture’s role in dementia risk, the effects of sedentary behavior on cardiovascular health, and interventions like yoga to improve sleep and mood in insomnia patients. His publications span clinical trials, observational studies, and meta-analyses addressing sleep’s broader implications for public health. Dr. Kline actively mentors students seeking research experience in sleep and exercise science, requiring a minimum 5-10 hour weekly commitment for 2 semesters. He emphasizes hands-on training in sleep assessment techniques like actigraphy and polysomnography. His work has been recognized through collaborations with organizations like the American Heart Association and the American College of Sports Medicine. Current projects include investigating the impact of circadian timing on energy balance and the relationship between sleep reactivity and health outcomes in adults with insomnia.

• Physical Activity
• Sleep Medicine
• Cardiometabolic Risk
• +۴ مورد دیگر

Alan Dombkowski is a Professor of Pediatrics at Wayne State University School of Medicine, specializing in molecular mechanisms of neurological disorders through genomic and bioinformatic approaches. Key research focus: Epileptogenic potential of cortical tubers in Tuberous Sclerosis Complex (TSC) Methods: Next-gen sequencing, microarrays, proteomics, and epigenetic analysis of human brain tissue Current projects funded by federal grants examining microRNA regulation and therapeutic targets in epilepsy Recent publications span: 2024: Cisplatin-induced cochlear synaptic proteomics 2023: Multi-omic biomarkers for prostate cancer aggressiveness 2021: Exosomal miRNA in TSC epilepsy 2018: Neuroinflammatory mechanisms in pediatric epilepsy Collaborations include Harry Chugani (neuroimaging), Diane Chugani (neurochemistry), Eishi Asano (epileptology), and Paul Stemmer (molecular pharmacology).

• Molecular Neuroscience
• Genomics
• Bioinformatics
• +۴ مورد دیگر

Jack R. Harkema is a University Distinguished Professor and holder of the Albert C. and Lois E. Dehn Endowed Chair in Veterinary Medicine at Michigan State University's College of Veterinary Medicine. He serves as Director of the Laboratory for Environmental & Toxicologic Pathology and the Mobile Air Research Laboratories (AirCARE 1 and 2). His research focuses on understanding how environmental and occupational air pollutants cause respiratory, cardiovascular, and autoimmune diseases using laboratory animal models. B.S. in Biology/Chemistry, Calvin College (1975) M.S. in Physiology, Michigan State University (1977) D.V.M., Michigan State University (1980) Postdoctoral Fellowship, Lovelace Respiratory Research Institute (1980-82) Residency in Veterinary Anatomic Pathology, UC Davis (1982-85) Ph.D. in Comparative Pathology, UC Davis (1985) Dr. Harkema's research interests center on environmental & occupational health with emphasis on air pollution effects. He investigates cellular and molecular targets for interventions against pollutant-induced diseases, focusing on ozone , particulate matter , and silica dust . His work explores how chronic diseases affect susceptibility to environmental toxins and develops dietary interventions for autoimmune conditions. Recent publications highlight his expertise in inhalation toxicology with studies on AHR pathway disruptions in hepatotoxicity, antiviral protein design for MERS-CoV inhibition, and autoimmune disease modulation through nutritional approaches. His article trends show strong emphasis on environmental health policy , inflammatory pathways , and translational research across toxicology and veterinary medicine. Career Achievement Award, Society of Toxicologic Pathology Val Vallyathan Award, American Thoracic Society Fellow of American Thoracic Society Board Certification, American College of Veterinary Pathologists As an educator, Dr. Harkema teaches general pathology , comparative pathology , and respiratory pathobiology . His service roles include past membership in US EPA's Clean Air Science Advisory Committee and leadership positions in the Environmental Health Policy Committee of the American Thoracic Society. The laboratory he directs develops mobile research platforms for community-based exposure studies, including Navajo Nation collaborations.

• Immunotoxicology
• Inflammation
• Respiratory Pathobiology
• +۳ مورد دیگر

Changyong Feng, PhD, is a Professor of Biostatistics and Computational Biology, Anesthesiology, and Dentistry at the University of Rochester Medical Center. He serves as Co-Director of the Department of Dentistry and holds a faculty position in the Department of Biostatistics and Computational Biology. He earned his PhD in Statistics from the University of Rochester in 2002. Dr. Feng’s research focuses on multivariate survival analysis, empirical processes theory, longitudinal data analysis, and statistical methods in epidemiology and clinical trials. His work spans interdisciplinary collaborations, including studies on anticoagulant efficacy in cardiovascular surgery, microbiome data analysis, and behavioral predictors of oral health. He has contributed to clinical trials, anesthesiology practices, and veterinary pharmacology. His expertise includes developing statistical models for complex biomedical data. Dr. Feng is affiliated with multiple departments at URMC, reflecting his role in bridging statistical methodologies with clinical and translational research. His publications address diverse topics from drug dosing optimization to influenza antibody dynamics. His research underscores the application of advanced statistical techniques to real-world medical challenges.

• Multivariate Survival Analysis
• Empirical Processes Theory
• Longitudinal Data Analysis
• +۳ مورد دیگر

Michael Brands serves as Vice Dean and Professor of Physiology at Augusta University's Medical College of Georgia, holding a Regents' Professorship with active appointments in both the Department of Physiology and The Graduate School. His dual administrative and academic roles include curriculum leadership in medical education. Education: Ph.D. in Physiology, University of Missouri - Columbia (1988) B.S. in Biology, Rockhurst University (1983) Research Focus: Dr. Brands investigates cardiovascular-renal integrative physiology with emphasis on hypertension mechanisms. His seminal work demonstrates insulin's chronic sodium-retaining action and proves that natriuresis in uncontrolled Type I diabetes stems from insulin deficiency rather than hyperglycemia. Current studies explore sex-specific immune regulation of blood pressure using rodent models. Publication Trends: Recent work (2020-2023) reveals critical immune-hypertension interactions, particularly how T-regulatory cells mediate sex differences in blood pressure control. His research consistently employs translational models examining renal mechanisms in hypertension development, with growing focus on developmental origins of cardiovascular disease. Awards: Institutional Service Award (2020) Four consecutive Exemplary Teaching Awards (2013-2017) Service & Leadership: Dr. Brands chairs the Animal Care and Use Leadership Committee while directing MCG's Cardiopulmonary Module. His extensive editorial service includes 30+ years on the American Journal of Physiology board and NIH fellowship reviews, reflecting significant contributions to hypertension research infrastructure.

• Cardiovascular physiology
• Renal physiology
• Hypertension
• +۵ مورد دیگر